ResourceSpectroscopy

LC/MS technologies have become a choice for HCP analysis

17 Mar 2020

In this application note, Agilent Technologies present a study to demonstrate an HCP analysis workflow that includes the AssayMAP Bravo platform for automated sample preparation, the 6545XT AdvanceBio LC/Q TOF for LC-MS/MS analysis, and the vendor-neutral software from proteinmetrics for data analysis.

6545XT AdvanceBio LC/Q-TOF

Agilent Technologies

The Agilent 6545XT AdvanceBio LC/Q-TOF system is designed to handle multiple workflows in biopharmaceutical characterization. When you need to access the most detailed information at the intact protein level, automatically confirm protein sequence at the peptide level, and confidently understand post-translational modifications, the 6545XT AdvanceBio Q-TOF delivers results you can trust.

(11)

Links

Tags

LC/MS technologies have become a choice for HCP analysis